On lighter skin, plaque psoriasis can appear red ... but there aren’t nearly as many pictures of psoriasis on Black skin. This often leads people to the conclusion that psoriasis only develops ...

Why ALZpath, GeneDX, 10x Genomics, Protagonist Therapeutics, and Recursion are among the most innovative biotech companies of 2025.

New data presented at the 2025 World Congress of Pediatric Dermatology annual meeting highlights the efficacy and safety of ...

Icotrokinra appears to be an effective treatment for adolescent patients with moderate to severe plaque psoriasis, according to a subgroup analysis of the ICONIC-LEAD study.

Icotrokinra is efficacious and safe for treating moderate to severe plaque psoriasis among adolescents and adults when compared with placebo.

Protagonist and Johnson & Johnson report positive Phase 3 data on icotrokinra in adolescent plaque psoriasis, showing high ...

Art Garfunkel is breaking the sound of silence around his experience with plaque psoriasis. | Art Garfunkel is breaking the ...

A growing momentum for earlier treatment of psoriasis has the potential to improve outcomes with oral therapies and biologics used to treat psoriasis, said Strober. The momentum can be traced to an ...

The favorable data provided support for two ongoing phase III, randomized, placebo-controlled trials of ESK-001 in moderate/severe plaque psoriasis. Two TYK2 inhibitors developed in China also ...

Recent study findings highlight the value of integrating behavioral modification and Health Belief Model–based education into ...

ORLANDO, Fla. — In moderate to severe plaque psoriasis, two highly selective oral TYK2 inhibitors produced a level of response in phase 2 studies suggesting that drugs in this class might rival ...

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful ...